Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study
- PMID: 10030326
- DOI: 10.1016/S0140-6736(98)07368-1
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study
Abstract
Background: In type 2 diabetes mellitus the aetiology of long-term complications is multifactorial. We carried out a randomised trial of stepwise intensive treatment or standard treatment of risk factors in patients with microalbuminuria.
Methods: In this open, parallel trial patients were allocated standard treatment (n=80) or intensive treatment (n=80). Standard treatment followed Danish guidelines. Intensive treatment was a stepwise implementation of behaviour modification, pharmacological therapy targeting hyperglycaemia, hypertension, dyslipidaemia, and microalbuminuria. The primary endpoint was the development of nephropathy (median albumin excretion rate >300 mg per 24 h in at least one of the two-yearly examinations). Secondary endpoints were the incidence or progression of diabetic retinopathy and neuropathy.
Findings: The mean age was 55.1 years (SD 7.2) and patients were followed up for 3.8 years (0.3). Patients in the intensive group had significantly lower rates of progression to nephropathy (odds ratio 0.27 [95% CI 0-10-0.75]), progression of retinopathy (0.45 [0.21-0.95]), and progression of autonomic neuropathy (0.32 [0.12-0.78]) than those in the standard group.
Interpretation: Intensified multifactorial intervention in patients with type 2 diabetes and microalbuminuria slows progression to nephropathy, and progression of retinopathy and autonomic neuropathy. However, further studies are needed to establish the effect of intensified multifactorial treatment on macrovascular complications and mortality.
Comment in
- ACP J Club. 1999 Jul-Aug;131(1):1
-
Preventive medicine in a diabetes clinic: an opportunity to make a difference.Lancet. 1999 Feb 20;353(9153):606-8. doi: 10.1016/S0140-6736(98)00366-3. Lancet. 1999. PMID: 10030322 No abstract available.
-
Psychological issues in diabetes.Lancet. 1999 Jul 3;354(9172):74. doi: 10.1016/s0140-6736(05)75342-3. Lancet. 1999. PMID: 10406391 No abstract available.
Similar articles
-
[Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno-2 study].Ugeskr Laeger. 1999 Jul 26;161(30):4277-85. Ugeskr Laeger. 1999. PMID: 10439688 Clinical Trial. Danish.
-
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial.Diabetologia. 2016 Nov;59(11):2298-2307. doi: 10.1007/s00125-016-4065-6. Epub 2016 Aug 16. Diabetologia. 2016. PMID: 27531506 Free PMC article. Clinical Trial.
-
Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design.Diabetes Res Clin Pract. 2010 Feb;87(2):228-32. doi: 10.1016/j.diabres.2009.09.025. Epub 2009 Nov 4. Diabetes Res Clin Pract. 2010. PMID: 19889469 Clinical Trial.
-
Albuminuria: a target for treatment of type 2 diabetic nephropathy.Semin Nephrol. 2007 Mar;27(2):172-81. doi: 10.1016/j.semnephrol.2007.01.002. Semin Nephrol. 2007. PMID: 17418686 Review.
-
Diabetic retinopathy, nephropathy and neuropathy. Generalized vascular damage in insulin-dependent diabetic patients.Horm Metab Res Suppl. 1992;26:68-70. Horm Metab Res Suppl. 1992. PMID: 1490695 Review.
Cited by
-
Dietary Interventions for Type 2 Diabetes: How Millet Comes to Help.Front Plant Sci. 2016 Sep 27;7:1454. doi: 10.3389/fpls.2016.01454. eCollection 2016. Front Plant Sci. 2016. PMID: 27729921 Free PMC article. Review.
-
Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.BMJ. 2011 Nov 24;343:d6898. doi: 10.1136/bmj.d6898. BMJ. 2011. PMID: 22115901 Free PMC article. Review.
-
Leptin mediate central obesity on the severity of cardiovascular autonomic neuropathy in well-controlled type 2 diabetes and prediabetes.J Transl Med. 2020 Oct 19;18(1):396. doi: 10.1186/s12967-020-02559-7. J Transl Med. 2020. PMID: 33076921 Free PMC article.
-
Diabetes and TelecommunicationS (DATES) study to support self-management for people with type 2 diabetes: a randomized controlled trial.BMC Public Health. 2018 Nov 12;18(1):1249. doi: 10.1186/s12889-018-6136-8. BMC Public Health. 2018. PMID: 30419893 Free PMC article. Clinical Trial.
-
The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial.BMC Public Health. 2010 Aug 5;10:457. doi: 10.1186/1471-2458-10-457. BMC Public Health. 2010. PMID: 20687924 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical